ascopost.com

Website beoordeling ascopost.com

TAP Homepage - The ASCO Post

 Gegenereerd op Maart 05 2026 11:22 AM

Oude statistieken? UPDATE !

De score is 45/100

SEO Content

Title

TAP Homepage - The ASCO Post

Lengte : 28

Perfect, uw title tag bevat tussen de 10 en 70 karakters.

Description

Lengte : 0

Erg slecht.we hebben geen meta description gevonden in uw website. Gebruik deze gratis online meta tags generator om een beschrijving te genereren.

Keywords

Erg slecht. We hebben geen meta keywords gevonden in uw website. Gebruik deze gratis online meta tags generator om keywords te genereren.

Og Meta Properties

Deze pagina maakt geen gebruik van Og Properties. Deze tags maken het sociale crawlers makkelijker uw pagina te indexeren.

Headings

H1 H2 H3 H4 H5 H6
1 1 16 5 10 0
  • [H1] More Top Stories
  • [H2] Sponsored Content
  • [H3] ‘Prostate Screening Saved My Life’—Is That Really True In Most Cases?
  • [H3] SABCS 2025: Top Picks From a Breast Cancer Specialist
  • [H3] How the Outlook on Fertility Preservation for Patients With Cancer Is Improving
  • [H3] Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC
  • [H3] Advanced Nonsquamous NSCLC: FDA Grants Accelerated Approval to Zongertinib
  • [H3] SPONSORED BY JOHNSON & JOHNSON
  • [H3] Rami S. Komrokji, MD, on Myelodysplastic Neoplasms: Classifying Risks Among Subsets of Disease
  • [H3] I Used AI to Supplement My Oncology Care—It Reshaped My Treatment Plan
  • [H3] Colorectal Cancer: ACS Report Shows Increasing Incidence, Mortality Rates in Younger Adults
  • [H3] Paolo Corradini, MD, on PMBCL and DLBCL: Comparing Outcomes With Axicabtagene Ciloleucel
  • [H3] ASCO’s First Living Guideline in GU Cancers Reflects Recent Practice-Changing Trials on Systemic Treatment of mCRPC
  • [H3] Leader in Global Cancer Care, Paul E. Goss, MD, PhD, FRCPC, FRCP Dies at 70
  • [H3] Research Suggests AI Pathology Models May Take Unreliable 'Shortcuts' to Identify Cancer Biomarkers
  • [H3] Nigel Russell, MD, on Acute Myeloid Leukemia: New Findings on FLAG-Ida and Gemtuzumab Ozogamicin
  • [H3] Introducing ASCO AI in Oncology
  • [H3] Lisocabtagene Maraleucel in Relapsed or Refractory MZL
  • [H4] Stephen Lam Chan, MD, FRCP, MRCP, on HCC: Pembrolizumab After Resection or Local Ablation
  • [H4] Matthew Strickland, MD, on Locally Advanced Gastric/GEJ Cancer: Tislelizumab Plus Chemoradiotherapy
  • [H4] Dina Ioffe, MD, on Disparities in HCC: Do They Affect Systemic Care?
  • [H4] Daniela Molena, MD, on Surgical Journey in the MATTERHORN Trial
  • [H4] Elena Elimova, MD, on HER2-Positive Gastroesophageal Cancer: Zanidatamab Plus Chemotherapy
  • [H5] Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes
  • [H5] CD123-Targeting ADC Shows Activity in AML and BPDCN
  • [H5] Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
  • [H5] Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence
  • [H5] Research Suggests AI Pathology Models May Take Unreliable Shortcuts to Identify Cancer Biomarkers
  • [H5] Charles Bennett and colleagues: The Inflation Reduction Act and Ibrutinib
  • [H5] Derek Raghavan: How I Discuss the Current Political Chaos When Patients Ask Health-Related Questions About It
  • [H5] Narjust Florez and Coral Olazagasti: Silence Is Complicity
  • [H5] Robert Peter Gale: Therapy With a TKI for EGFR-Variant Lung Adenocarcinoma: Lessons From CML?
  • [H5] Raj Mohan on Kindness, Mercy, Empathy, Compassion: Are They Relevant in the Era of Robotics and AI?

Afbeeldingen

We vonden 25 afbeeldingen in de pagina.

23 alt attributen ontbreken. Voeg alternatieve text toe zodat zoekmachines beter kunnen beoordelen wat het onderwerp van de afbeeldingen is.

Text/HTML Ratio

Ratio : 10%

De ratio van text tot HTML code is below 15 procent, dit betekent dat uw pagina waarschijnlijk meer tekst nodig heeft.

Flash

Perfect, geen Flash content gevonden in uw website.

Iframe

Jammer, u heeft Iframes in uw website, dit betekent dat deze content niet kan worden geïndexeerd.

Herschreven URL

Perfect. Uw links zien er vriendelijk uit!

Underscores in de URLs

Perfect! Geen underscores gevonden in uw URLs.

In-page links

We vonden een totaal van 74 links inclusie 0 link(s) naar bestanden

Ankertekst Type samenstelling
- Intern doFollow
About The ASCO Post Intern doFollow
Editorial Board Intern doFollow
Rights and Permissions Intern doFollow
Contact Intern doFollow
Subscribe Intern doFollow
FDA Update Intern doFollow
Journal Spotlight Intern doFollow
Expert's Corner Intern doFollow
In the Clinic Intern doFollow
View By Issue Intern doFollow
View All Intern doFollow
2026 ASCO GU Intern doFollow
2026 ASCO GI Intern doFollow
SUO 2025 Intern doFollow
SABCS 2025 Intern doFollow
ASH 2025 Intern doFollow
Calendar Intern doFollow
View All Intern doFollow
AI in Oncology Intern doFollow
Breast Cancer Intern doFollow
Lung Cancer Intern doFollow
Prostate Cancer Intern doFollow
Lymphoma Intern doFollow
Cardio-oncology Intern doFollow
View All Intern doFollow
Charles Bennett and colleagues: The Inflation Reduction Act and Ibrutinib Intern doFollow
Derek Raghavan: How I Discuss the Current Political Chaos When Patients Ask Health-Related Questions About It Intern doFollow
Narjust Florez and Coral Olazagasti: Silence Is Complicity Intern doFollow
Robert Peter Gale: Therapy With a TKI for EGFR-Variant Lung Adenocarcinoma: Lessons From CML? Intern doFollow
Raj Mohan on Kindness, Mercy, Empathy, Compassion: Are They Relevant in the Era of Robotics and AI? Intern doFollow
Newsreels Intern doFollow
Video Roundtables Intern doFollow
Podcasts Intern doFollow
‘Prostate Screening Saved My Life’—Is That Really True In Most Cases? Intern doFollow
SABCS 2025: Top Picks From a Breast Cancer Specialist Intern doFollow
Issues in Oncology Intern doFollow
How the Outlook on Fertility Preservation for Patients With Cancer Is Improving Intern doFollow
Bladder Cancer Intern doFollow
Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC Intern doFollow
Advanced Nonsquamous NSCLC: FDA Grants Accelerated Approval to Zongertinib Intern doFollow
Hepatobiliary Cancer Intern doFollow
Stephen Lam Chan, MD, FRCP, MRCP, on HCC: Pembrolizumab After Resection or Local Ablation Intern doFollow
Gastroesophageal Cancer Intern doFollow
Gastrointestinal Cancer Intern doFollow
Matthew Strickland, MD, on Locally Advanced Gastric/GEJ Cancer: Tislelizumab Plus Chemoradiotherapy Intern doFollow
Dina Ioffe, MD, on Disparities in HCC: Do They Affect Systemic Care? Intern doFollow
Daniela Molena, MD, on Surgical Journey in the MATTERHORN Trial Intern doFollow
Elena Elimova, MD, on HER2-Positive Gastroesophageal Cancer: Zanidatamab Plus Chemotherapy Intern doFollow
Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes Intern doFollow
CD123-Targeting ADC Shows Activity in AML and BPDCN Intern doFollow
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds Intern doFollow
Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence Intern doFollow
Research Suggests AI Pathology Models May Take Unreliable Shortcuts to Identify Cancer Biomarkers Intern doFollow
Hematologic Malignancies Intern doFollow
Rami S. Komrokji, MD, on Myelodysplastic Neoplasms: Classifying Risks Among Subsets of Disease Intern doFollow
I Used AI to Supplement My Oncology Care—It Reshaped My Treatment Plan Intern doFollow
Colorectal Cancer: ACS Report Shows Increasing Incidence, Mortality Rates in Younger Adults Intern doFollow
Paolo Corradini, MD, on PMBCL and DLBCL: Comparing Outcomes With Axicabtagene Ciloleucel Intern doFollow
ASCO’s First Living Guideline in GU Cancers Reflects Recent Practice-Changing Trials on Systemic Treatment of mCRPC Intern doFollow
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, FRCPC, FRCP Dies at 70 Intern doFollow
Leukemia Intern doFollow
Nigel Russell, MD, on Acute Myeloid Leukemia: New Findings on FLAG-Ida and Gemtuzumab Ozogamicin Intern doFollow
Introducing ASCO AI in Oncology Intern doFollow
Lisocabtagene Maraleucel in Relapsed or Refractory MZL Intern doFollow
Social Media Hub Extern doFollow
Bots not welcome here Intern noFollow
Editorial Board Intern doFollow
Advertising Intern doFollow
Disclosures Intern doFollow
Contact Intern doFollow
Privacy Policy Extern doFollow
Disclaimer Intern doFollow
ASCO.org Extern doFollow

SEO Keywords

Keywords Cloud

psa screening advertisement therapy oncology fertility patients lung cancer prostate

Keywords Consistentie

Keyword Content Title Keywords Description Headings
cancer 13
oncology 6
patients 6
advertisement 4
fertility 3

Bruikbaarheid

Url

Domein : ascopost.com

Lengte : 12

Favicon

Goed, uw website heeft een favicon.

Printbaarheid

Jammer. We vonden geen Print-Vriendelijke CSS.

Taal

Goed. Uw ingestelde taal is en.

Dublin Core

Deze pagina maakt geen gebruik van Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Uw ingestelde Charset is UTF-8.

W3C Validiteit

Fouten : 0

Waarschuwingen : 0

E-mail Privacy

Geweldig er is geen e-mail adres gevonden als platte tekst!

Niet ondersteunde HTML

Geweldig! We hebben geen niet meer ondersteunde HTMl tags gevonden in uw HTML.

Speed Tips

Geweldig, uw website heeft geen tabellen in een tabel.
Jammer, uw website maakt gebruik van inline styles.
Jammer, uw website heeft teveel CSS bestanden (meer dan 4).
Jammer, uw website heeft teveel JS bestanden (meer dan 6).
Perfect, uw website haalt voordeel uit gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimalisatie

XML Sitemap

Geweldig, uw website heeft een XML sitemap.

http://www.ascopost.com/sitemap/

Robots.txt

https://ascopost.com/robots.txt

Geweldig uw website heeft een robots.txt bestand.

Analytics

Perfect, uw website heeft een analytics tool.

   Google Analytics

PageSpeed Insights

Device
Categorieën

Free SEO Testing Tool

Website review is een gratis tool waarmee u eenvoudig uw website kunt analyseren